Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (151-160 of 380) with videos related to

Pageof 38
Sort By:
Haematologica|March 12, 2010
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA groupFrancisco Cervantes, Pilar López-Garrido, María-Isabel Montero, et al.
Haematologica|October 18, 2006
The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myelomaMaría Eugenia Sarasquete, Ramón García-Sanz, Adriana Armellini, et al.
Blood|January 31, 2013
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMTEsa Jantunen, Ariane Boumendil, Herve Finel, et al.
Bone Marrow Transplantation|February 23, 2022
Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity surveyJakob R Passweg, Helen Baldomero, Christian Chabannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation RegistryRoel J W van Kampen, Carmen Canals, Harry C Schouten, et al.
Hematological Oncology|September 3, 2019
m7FLIPI and targeted sequencing in high-risk follicular lymphomaMarc Sorigue, Anna Oliveira, Santiago Mercadal, et al.
American Journal of Hematology|October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working partySaad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.
Cancers|April 14, 2025
Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE StudyAnna Sureda, Ramón García-Sanz, Eva Domingo-Domenech, et al.
Haematologica|December 11, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcomeStephen P Robinson, Anna Sureda, Carmen Canals, et al.
Pageof 38

Showing results (151-160 of 380) with videos related to

Sort By:
Pageof 38
Haematologica|March 12, 2010
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA groupFrancisco Cervantes, Pilar López-Garrido, María-Isabel Montero, et al.
Haematologica|October 18, 2006
The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myelomaMaría Eugenia Sarasquete, Ramón García-Sanz, Adriana Armellini, et al.
Blood|January 31, 2013
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMTEsa Jantunen, Ariane Boumendil, Herve Finel, et al.
Bone Marrow Transplantation|February 23, 2022
Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity surveyJakob R Passweg, Helen Baldomero, Christian Chabannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation RegistryRoel J W van Kampen, Carmen Canals, Harry C Schouten, et al.
Hematological Oncology|September 3, 2019
m7FLIPI and targeted sequencing in high-risk follicular lymphomaMarc Sorigue, Anna Oliveira, Santiago Mercadal, et al.
American Journal of Hematology|October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working partySaad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.
Cancers|April 14, 2025
Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE StudyAnna Sureda, Ramón García-Sanz, Eva Domingo-Domenech, et al.
Haematologica|December 11, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcomeStephen P Robinson, Anna Sureda, Carmen Canals, et al.
Pageof 38